As shown in Figure 1A, a significant higher MMP-2 levels was observed among patients with lung cancer than benign diseases (6.1 ± 1.1 ng/ml versus 2.2 ± 0.6 ng/ml, P = 0.0033). Here, MMP2 is linked to lung carcinoma.